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Abstract
Objective—We and others have previously shown that RhoA-dependent stimulation of 
myocardin related transcription factor (MRTF) nuclear localization promotes smooth muscle cell 
(SMC) marker gene expression. The goal of the present study was to provide direct in vivo 
evidence that actin polymerization by the diaphanous-related formins contributes to the regulation 
of SMC differentiation and/or phenotype.
Approach and Results—Conditional cre-based genetic approaches were used to over-express a 
well-characterized dominant negative variant of mDia1 (DNmDia) in SMC. DNmDia expression 
in SM22 expressing cells resulted in embryonic and perinatal lethality in ~20% of mice due to 
defects in myocardial development and SMC investment of peripheral vessels. While most 
DNmDia+/SM22Cre+ mice exhibited no overt phenotype, the re-expression of SMC differentiation 
marker gene expression that occurs following carotid artery ligation was delayed, and this effect 
was accompanied by a significant decrease in MRTF-A nuclear localization. Interestingly, 
neointima growth was inhibited by expression of DNmDia in SMC and this was likely due to a 
defect in directional SMC migration and not to defects in SMC proliferation or survival. Finally, 
by using the tamoxifen-inducible SM MHCCreERT2 line, we showed that SMC-specific induction 
of DNmDia in adult mice decreased SMC marker gene expression.
Conclusions—Our demonstration that diaphanous-related formin signaling plays a role in heart 
and vascular development and the maintenance of SMC phenotype provides important new 
evidence that Rho/actin/MRTF signaling plays a critical role in cardiovascular function.
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INTRODUCTION
Smooth muscle cell (SMC) differentiation plays an important role in vascular development 
and maintenance. Although medial SMC express a repertoire of contractile-associated 
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differentiation markers, they do not terminally differentiate even in adult animals. 
Phenotypically modulated SMC that exhibit decreased differentiation marker gene 
expression and increased growth, migration, and matrix production have been shown to 
contribute to the progression of several important cardiovascular diseases including 
atherosclerosis, hypertension, and restenosis (1, 2). Therefore, a better understanding of the 
signaling mechanisms that control these SMC functions will be critical.
Most SMC differentiation marker genes including SM myosin heavy chain (SM MHC), SM 
α-actin, calponin, and SM22 are regulated by serum response factor (SRF), a ubiquitously 
expressed MADS box transcription factor that binds to conserved CArG (CC(A/T)6GG) 
elements within the promoters of these genes (2). The cardiac and SMC selective SRF co-
factor, myocardin, strongly transactivates SMC-specific transcription and is required for 
SMC differentiation in vivo (3). Two myocardin-related transcription factors, MRTF-A and 
MRTF-B, have also been identified. Although they are expressed more widely, their 
importance in the regulation of SMC differentiation marker gene expression is supported by 
the phenotypes of global and tissue-specific knockouts (4–7). We and others have 
demonstrated that RhoA-mediated actin polymerization stimulates MRTF nuclear 
localization and is critical for SMC marker gene expression in at least some SMC cell-types 
(8–11). However, direct in vivo evidence that this mechanism plays a significant role in the 
regulation of SMC differentiation or phenotypic modulation is lacking.
We have previously identified a number of signaling mechanisms that control RhoA activity 
in SMC (12, 13) and have characterized the pathways downstream of RhoA that regulate 
MRTF-dependent SMC-specific transcription (14, 15). The Rho-associated kinases (ROCK 
1 and 2) increase actin polymerization indirectly through a kinase cascade that inhibits 
cofilin’s ability to sever F-actin, and they also promote stress fiber formation by enhancing 
actin fiber bundling and cell contractility (16, 17). However, we have shown that inhibition 
of ROCK signaling only partially inhibited SMC-specific promoter activity, suggesting that 
additional RhoA effectors were important. The diaphanous-related formins (DRFs), mDia1 
and mDia2, are RhoA effectors that directly catalyze linear actin polymerization in 
cooperation with profilin (18–21). We have shown that both are highly expressed in SMC, 
and when activated, strongly up-regulate SMC marker gene expression (14). Importantly, 
siRNA-mediated knockdown of mDia1 and mDia2 in primary rat aortic SMC resulted in a 
significant reduction in SMC-specific promoter activity, endogenous SMC marker gene 
expression, and MRTF nuclear localization (14).
RhoA signaling also regulates the actin and adhesion dynamics that control cell migration 
and division. Using fluorescent biosensors, Pertz et al. detected RhoA activity near the 
leading edge of migrating cells where it is thought to promote actin-based cell protrusion 
(22). RhoA activity is also high at the rear of migrating cells where it induces the contractile 
forces necessary for trailing edge retraction Several studies have shown that mDia1 and 
mDia2 catalyze the linear actin polymerization that is required for filopodia formation (23). 
RhoA signaling also controls cell adhesion by modulating focal adhesion formation and 
RhoA dependent activation of mDia2 at the cleavage furrow may be important for 
cytokinesis (24, 25). Given its pleiotropic effects on nearly all of the parameters that define 
SMC phenotype it will be critical to further study RhoA/mDia/actin signaling in SMC.
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The goal of the present study was to define the contributions of mDia-mediated actin 
polymerization to SMC phenotype in vivo. We used genetic models to inhibit DRF signaling 
in SMCs during cardiovascular development, and we studied the effects of mDia inhibition 
on SMC phenotypic modulation in adult mice subjected to carotid artery ligation. Our 
results indicate that mDia signaling was required for normal cardiovascular development, 
and that inhibition of mDia signaling attenuated SMC differentiation marker gene expression 
but reduced neointima formation by inhibiting SMC migration.
MATERIALS AND METHODS
Materials and Methods are available in the online-only Data Supplement.
RESULTS
Inhibition of mDia signaling in SM22-expressing cells led to some embryonic/perinatal 
lethality
To determine the contributions of actin polymerization to the regulation of SMC 
differentiation and/or phenotype in vivo, we used a genetic approach to over-express a 
dominant negative variant of mDia1 (F1FHΔ1) specifically in SMC (Figure 1a). Because 
mDia1 and mDia2 are RhoA effectors with considerable functional overlap (26, 27), it is 
important to note that this variant inhibits the function of all DRFs by dimerizing with 
endogenous proteins and/or binding nonproductively with barbed actin filaments (18, 28). 
Another consideration for our approach was that DNmDia inhibits actin polymerization 
more specifically than alternative interventions that target Rho and its many effectors or 
ROCK and its many substrates. In excellent agreement with our previous demonstration that 
DNmDia inhibited the activities of exogenous SMC-specific promoters (14), over-
expression of DNmDia inhibited the endogenous expression of multiple SMC-specific 
marker genes and the nuclear localization of MRTF-A in S1P-treated 10T1/2 cells (Figure 
1b–d).
Flag-tagged DNmDia was cloned into a previously described transgene construct in which 
the constitutive expression of DNmDia (driven by a fragment of the β-actin promoter) is 
inhibited by the upstream insertion of a floxed EGFP-Stop cassette (Figure 2a and (29, 30)). 
DNmDia transgenic mice were generated on a C57BL/6 background and were crossed to a 
well-characterized SM22Cre line (31) that expresses Cre in most SMC subsets and in the 
developing myocardium (Supp. Figure Ia and (32)). Although many DNmDia+/SM22Cre+ 
mice were viable, the number that reached adulthood was approximately 20% less than that 
expected by Mendelian ratios (Table 1). A number of DNmDia+/SM22Cre+ mice died in 
utero with non-viable embryos beginning to appear at around E15.5. Hemorrhage was 
detected in 6 out of 17 DNmDia+/SM22Cre+ embryos between E15.5 – E18.5 and was most 
visible near the smaller, more peripheral blood vessels of the head, limbs, and body wall 
(Figure 2b). Immunohistologic examination of these mice revealed severely dilated blood 
vessels that were poorly invested with SM αactin expressing cells (Figure 2c). Importantly, 
SMC coverage of larger blood vessels like the aorta and carotid arteries was not significantly 
affected in hemorrhagic DNmDia+/SM22Cre+ embryos (Figure 2c).
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A subset of DNmDia+/SM22Cre+ mice also exhibited cardiac abnormalities, including 
ventricular septal defect and hypoplasticity of the ventricular wall and septum at E18.5 
(Figure 2d). Since this SM22Cre line can drive Cre expression in the embryonic heart, it was 
likely that DRF signaling was important for myocardial cell proliferation/survival during this 
developmental window. Indeed, phospho-histone H3 staining revealed a dramatic reduction 
in myocardial cell proliferation in DNmDia+/SM22Cre+ mice. A significant number of 
DNmDia+/SM22Cre+ mice died perinatally and while these mice appeared fairly normal at 
birth they quickly became runted and did not survive past postnatal day 9. All dead pups had 
milk in their stomach, suggesting that the runted phenotype was not due to a nursing defect. 
Histological analysis revealed lung congestion and hearts with thin ventricular walls and low 
phospho-histone H3 expression, again suggestive of heart function defects in these mice 
(Supp. Figure II).
Importantly, the DNmDia+/SM22Cre+ mice that survived to adulthood had no overt 
phenotype and a normal lifespan. Somewhat surprisingly, heart and vessel morphology and 
SMC marker gene expression were unaffected even though DNmDia was strongly expressed 
in these tissues (Figure 2e).
DNmDia expression altered SMC phenotype following arterial injury
It is clear that the activation of compensatory pathways during development can modify the 
phenotype of genetically modified mice and that the application of acute stresses can 
unmask previously undetected effects of genetic modifications. The lack of phenotype in 
adult DNmDia+/SM22Cre+ provided us with an excellent model for examining the effects of 
mDia signaling on SMC phenotypic modulation following vascular injury. To this end, we 
subjected DNmDia+/SM22Cre+ and control littermates to a carotid artery ligation procedure 
that results in a significant neointima by 21 days and a down-regulation of SMC 
differentiation marker gene expression in medial SMC that peaks at ~4–5 days post-injury 
and eventually returns to normal (Figure 3 and (33)). Notably we observed no statistical 
significant difference in vessel diameter between uninjured and ligated arteries in either 
control or DNmDia+/SM22Cre+ animals.
In excellent agreement with the Western blot data shown in Figure 2e, immunohistochemical 
analyses revealed no differences in SM α-actin, SM MHC, or calponin expression between 
uninjured arteries from control and DNmDia+/SM22Cre+ mice (Figure 3 and Suppl. Figure 
III). As expected, differentiation marker expression in medial SMC was reduced at 4 days 
post-ligation in control mice, and a similar reduction was observed in DNmDia+/SM22Cre+ 
animals (Figure 3c). However, while SMC differentiation marker gene expression was 
already returning to baseline by day 7 post-injury in control mice, it remained down-
regulated in DNmDia+/SM22Cre+ mice (Figure 3a, c). This difference was not apparent at 
the 21-day time-point (Figure 3a), suggesting that the recovery of SMC marker gene 
expression was delayed but not completely inhibited in this model. Importantly, the 
differences in SMC marker gene expression at the 7-day time point were accompanied by 
reductions in MRTF-A nuclear localization (Figure 3d and Suppl. Figure IVa), an effect 
likely due to decreased actin polymerization in DNmDia-expressing SMC.
Weise-Cross et al. Page 4













The ability of DNmDia to inhibit SMC marker gene expression in this model suggested that 
these cells were more phenotypically modulated. However, injured vessels from DNmDia+/
SM22Cre+ mice had significantly less neointima formation and overall stenosis than 
controls (Figure 3a, b) and reduced collagen deposition (Supp. Figure IVb). Taken together, 
these data suggest that mDia signaling has complex effects on SMC phenotype and provide 
strong evidence that SMC differentiation and growth/migration are not mutually exclusive 
and are independently regulated.
Inhibition of mDia signaling reduced directional SMC migration
Extensive evidence including the results from elegant lineage tracing studies indicates that 
the majority of neointima SMC originate from the medial SMC layer and that injury-induced 
increases in SMC migration and proliferation are critical for neointima formation (34). 
Although it is well known that RhoA signaling has complex and sometimes biphasic effects 
on these processes (35), the role of mDia signaling in SMC is less clear. Thus, we performed 
additional analyses to identify the mechanism for decreased neointima formation in 
DNmDia+/SM22Cre+ mice.
Although control mice exhibited larger neointimas than DNmDia mice at 21 days post-
ligation, we observed similar percentages of proliferating cells within the neointima at day 7 
(Figure 3e). In agreement with the lack of effect on neointimal cell proliferation we 
observed in vivo, knockdown of mDia1, mDia2, or both in mouse aortic SMC or 10T1/2 
cells had no significant effects on cell proliferation as measured by phospho-histone H3 
staining or MTT assays (Supp. Figure Va–c). In addition, mDia knockdown or DNmDia 
overexpression had no effect on cell cycle progression as measured by flow cytometry of 
DAPI-stained cells, and results from TUNEL and lactate dehydrogenase release assays 
revealed no effects on apoptosis or cytotoxicity, respectively (Supp. Figure Vd–g). 
Furthermore, DNmDia+/Rosa26+/SM22Cre+ mice showed uniform expression in the aorta, 
bladder, lungs, and heart, indicating no significant cell death in DNmDia+ cells in vivo 
(Supp. Figure Ia).
Based upon these results and previous studies demonstrating that mDia-mediated actin 
polymerization was required for filopodia formation and cell migration (23, 36), we 
hypothesized that the decrease in neointima size in DNmDia+/SM22Cre+ mice resulted from 
a decrease in migration from the medial SMC layer. In strong support of this, siRNA-
mediated knockdown of mDia1, mDia2, or both (Figure 4c) resulted in a 50–70% decrease 
in SMC migration in transwell assays (Figure 4a) and a significant decrease in scratch 
wound closure in 10T1/2 cells (Figure 4b). Interestingly, live cell tracking studies 
demonstrated that sub-confluent cells expressing DNmDia-mCherry were capable of random 
migration and that these cells migrated similar distances to control cells (Figure 5a). 
Although DNmDia-expressing and control cells also traversed similar distances in scratch 
wound assays, directional migration toward the wound was significantly inhibited in 
DNmDia expressing cells (Figure 5b–c, Supp. Videos I–II), strongly suggesting that 
inhibition of mDia signaling in SMC leads to defects in directional migration and/or cell 
polarity. Accordingly, DNmDia-expressing cells exhibited significant polarity defects as 
evidenced by lamellipodia formation in multiple directions (Figure 5d, Supp. Figure VIa) 
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and failure of the microtubule organizing center (MTOC) to orient toward the scratch wound 
(Figure 5e–f, Supp. Figure VIb–c).
mDia signaling maintains SMC differentiation in adults
The effects of DNmDia expression in SM22-expressing cells during development were 
incompletely penetrant, and it is likely that stochastic differences in the timing and/or level 
of DNmDia expression during a critical developmental window helps explain these results. 
Compensatory pathways may also play a role and our demonstration that DNmDia had no 
effect on SMC function at baseline in adults, but delayed the re-expression of SMC 
differentiation marker gene expression following carotid injury supports this idea. To test 
this hypothesis further, we crossed DNmDia+ mice with the SMMHC-CreERT2 line that 
allowed us to activate DNmDia expression specifically in SMC in adult mice, effectively by-
passing any compensatory pathways activated during development. As shown in Supp. 
Figure Ib, intraperitoneal injection of tamoxifen for 5 consecutive days activated Cre in the 
SMC layers of the aorta, bladder, lungs, and stomach in this model although activation of 
DNmDia expression was somewhat more variable (Figure 6b, Supp. Figure VII). 
Importantly, tamoxifen treatment of DNmDia+/SMMHC-CreERT2 mice resulted in a 
significant down-regulation of SM MHC gene expression in the aorta, bladder, and stomach 
and a significant down-regulation of all SMC differentiation marker genes in the bladder that 
exhibited strong and consistent DNmDia expression (Figure 6, Supp. Figure VII).
DISCUSSION
To our knowledge, these results provide the first in vivo evidence that signaling through the 
diaphanous-related formins is critical for SMC differentiation marker gene expression and 
proper heart development. Our results also suggest that inhibition of mDia signaling inhibits 
neointima formation by attenuating directed SMC migration from the medial SMC layer of 
injured vessels.
Although 80% of DNmDia+/SM22Cre+ mice exhibited no detectable phenotype, a 
significant number died during embryonic development or perinatally. Several embryos 
exhibited significant hemorrhaging, suggesting that vessel integrity was affected by SMC-
specific expression of DNmDia. Although the larger vessels were properly layered with SM 
α-actin-expressing cells, there appeared to be defects in SMC/pericyte investment of smaller 
vessels. Carramusa et al. demonstrated that mDia1 was required for proper E-cadherin 
junction formation between MCF-7 cells (37) and inhibition of EC-SMC or SMC-SMC 
junctions in DNmDia-expressing cells could contribute to the hemorrhage observed. This 
phenotype was similar to that observed in global S1P2/S1P3 receptor double knockout mice 
(38), which also showed a lack of SMC/pericyte investment of smaller blood vessels. Our 
previous studies demonstrating that S1P and S1P-dependent RhoA signaling were critical 
for SMC differentiation (12, 13) provide additional functional links between these two 
models.
Many deaths were attributed to heart defects that included considerable hypoplasticity. Like 
many SMC differentiation markers, SM22 is expressed in the myocardium during 
embryonic development, and our Cre-based expression model resulted in permanent and 
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constitutive expression of DNmDia in myocardial cells potentially as early as E8.5(32). 
Thus, the defects in heart development observed were likely due to myocardial cell-
autonomous effects of DNmDia on cell proliferation. Since the IVS forms primarily by 
proliferative expansion of muscular tissue of the outer curvature (39), the VSDs observed 
may have been due to decreased protrusion of this structure from the apical wall. However, 
we cannot rule out a potential effect on the endocardial cushions that contribute to the 
anterior portion of the IVS. A number of sarcomeric protein mutations cause cardiac septal 
defects (40) and it is possible that abnormal sarcomere organization due to defects in linear 
actin polymerization in DNmDia-expressing cells could be involved. Interestingly, neither 
knockdown of mDia1 and mDia2 nor expression of DNmDia had significant effects on 
proliferation in SMC. Gopinath et al. reported that mDia1 knockdown in c2c12 skeletal 
muscle cells inhibited cell cycle progression, perhaps suggesting that proliferation in striated 
muscles is more sensitive to mDia inhibition (41). Taken together, our results demonstrate 
that DRF signaling plays a functional role in normal cardiac development and blood vessel 
maturation. Nevertheless, additional studies using Cre driver lines that are more cardiac-
specific will be needed to determine the precise role of mDia/DRF signaling on 
cardiomyocyte proliferation and heart development.
We did not detect differences in SMC marker gene expression in the DNmDia+/SM22Cre+ 
that survived to adulthood. However, we observed developmental defects in SMC investment 
and vessel integrity and a delay in the re-expression of SMC marker genes following carotid 
artery in these animals. When coupled with the decrease in SMC marker gene expression 
upon activation of DNmDia expression in adult SMC, these data strongly support our 
original hypothesis that mDia-mediated actin polymerization plays a role in the regulation of 
SMC phenotype in vivo. It is important to note that because DNmDia expression in our 
model occurs only after initial SM22 activation, we do not yet know whether mDia signaling 
is required for the initial differentiation of SMC or whether it is more important for SMC 
maturation and/or maintenance.
DNmDia+/SM22Cre+ mice exhibited reduced neointima formation following carotid artery 
ligation. These results are in good agreement with a study by Toure et al (42), who observed 
reduced neointimal formation in global mDia1 knockout mice. Since SM22α expression has 
been detected in some myeloid cells (43, 44) and macrophage infiltration has been shown to 
promote neointima formation, it is difficult to completely eliminate a role for these cells in 
our model. However, since the majority of neointima cells in our injury model are SMC, we 
believe that mDia signaling plays a SMC autonomous role in neointimal formation most 
likely by promoting SMC migration from the medial layer. It is well known that mDia1 and 
mDia2 control linear actin polymerization (36) and are required for filopodia formation and 
cell migration in cultured cells (45–47) and in vivo (48–50). Our data indicated that 
DNmDia expression had no effect on overall SMC movement, but instead inhibited 
directional migration. A growing body of evidence suggests that the diaphanous-related 
formins have important effects on microtubule organization and on cell polarity (51–57), and 
our demonstration that MTOC and lamellipodia positioning were altered in DNmDia 
expressing cells strongly supports these results. Thus, it will be critical to identify the 
signaling mechanisms downstream of the diaphanous-related formins that regulate cell 
polarity in SMCs. Interestingly, the reduction in collagen deposition in the DNmDia-
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expressing mice following ligation suggests that MRTF-A-mediated fibrosis may contribute 
to the injury response.
In summary, our data demonstrate that diaphanous-related formin-mediated actin 
polymerization plays a role in proper heart and vascular development, the maintenance of 
the differentiated SMC, and directional SMC migration. These results provide important 
new evidence that the Rho/actin/MRTF signaling axis plays a critical role in controlling 
SMC phenotype and support additional studies on this pathway during cardiovascular 
development and the disease progression.
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We have previously shown that mDia-mediated actin polymerization regulates smooth 
muscle cell differentiation in vitro, but comprehensive in vivo studies of this mechanism 
are lacking. This study is the first to demonstrate that diaphanous-related formin-
mediated actin polymerization is critical for normal heart development and for the 
regulation of SMC phenotype following vessel injury.
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Figure 1. DNmDia expression inhibited SM-specific marker expression
A) Schematic of full-length and dominant negative mDia1. FH, formin homology domain; 
GBD, GTPase-binding domain; DID, diaphanous inhibitory domain; DAD, diaphanous 
autoinhibitory domain. B) 10T1/2 cells transfected with DNmDia or empty expression 
vector were serum-starved, and treated with sphingosine-1-phosphate (S1P) for 16 hr. 
Endogenous SMC marker expression was detected by immunoblotting. C) 10T1/2 cells 
expressing mCherry empty vector (EV) or mCherry-DNmDia were serum-starved, treated 
with S1P for 4 min, and then fixed. Localization of endogenous MRTF-A was determined by 
immunohistochemistry. D) Quantification of MRTF-A nuclear localization from three 
separate S1P-treated experiments with over 100 cells counted per condition. * p < 0.05.
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Figure 2. DNmDia expression in SM22-expressing cells resulted in some embryonic/perinatal 
death
A) Schematic of the Cre-dependent transgene construct used to drive DNmDia. B) Gross 
images of littermate control and hemorrhagic DNmDia+/SM22Cre+ embryos. C) H&E and 
SM α-actin staining of the indicated blood vessels from DNmDia+/SM22Cre+ and littermate 
control mice. Arrows point to a severely dilated vessel with incomplete SMC investment. D) 
H&E and phospho-histone H3 staining of hearts from DNmDia+/SM22Cre+ and control 
mice at E18.5. Arrow points to ventricular septal defect. E) Western blot for SMC 
differentiation marker gene expression in the aorta, bladder, and heart from littermate control 
(WT) and phenotypically normal 4-week-old DNmDia+/SM22Cre+ (DN) mice.
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Figure 3. DNmDia delayed SM marker gene re-expression and reduced neointima formation 
after carotid artery ligation
Adult DNmDia+/SM22Cre+ mice and littermate controls were subjected to ligation of the 
right carotid artery just below the bifurcation. Left carotid arteries served as uninjured 
controls. A) Carotid arteries were harvested at 7- or 21-days post-ligation, fixed, and 
embedded in paraffin. DAB staining for SM α-actin was performed on 12 μm sections. 
Arrows indicate the internal elastic lamina (IEL). B) Neointimal area 500 μm downstream of 
the ligation was quantified from 12 μm H&E-stained paraffin sections at 7- and 21-days 
post-ligation using ImageJ and is expressed relative to medial area. Percent lumen stenosis 
was calculated as intimal area/total area encompassed by the IEL. n=at least 7 per genotype, 
per time-point. C) Carotid arteries were harvested from mice at 4 days or 7 days post-
ligation and frozen in OCT medium. Immunofluorescence staining for SM MHC and 
Calponin was performed on 8 μm sections. ImageJ was used to quantify fluorescence 
intensity. n=at least 3 per genotype, per time-point. D) MRTFA localization was imaged by 
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con-focal immunofluorescence in frozen sections taken from control and injured carotid 
arteries 7-days after ligation. MRTF-A nuclear localization was determined using ImageJ 
and is expressed relative to DAPI co-staining. n=at least 3 per genotype. E) Phospho-histone 
H3 staining of paraffin sections from 7-day ligated WT and DNmDia carotid arteries. pH3-
positive cells were counted and expressed as a percentage of DAPI-stained cells in the 
intima. Arrowheads point to IEL. n=at least 3 per genotype. For all measurements * p < 
0.05.
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Figure 4. mDia knockdown inhibited SMC migration
A) siRNA was used to knock down mDia1, mDia2, or both in primary mouse aortic SMC. 
Equal numbers of mouse SMCs from each knockdown group were plated onto fibronectin-
coated transwell inserts and migration was stimulated for 8 hours by addition of 20 ng/ml 
PDGF-BB to the bottom well. Following fixation and staining with Crystal Violet, SMC 
migration was evaluated in three separate experiments and expressed relative to migration of 
control cells set to 100%. *p < 0.05. B) Confluent cultures of control (NTC) and mDia1/2 
knockdown 10T1/2 cells were scratched with a P1000 pipette tip and visualized every three 
hours. Shown are time-points immediately (0h) and 15h after scratch wounding. C) Western 
blot illustrating mDia1/mDia2 knockdown in our mouse aortic SMC and 10T1/2 cell culture 
models 72 hr after siRNA transfection.
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Figure 5. DNmDia reduced directional migration
A) Subconfluent cultures of 10T1/2 cells were transfected with mCherry-EV (Control) or 
mCherry-DNmDia. Live-cell imaging was used to monitor random (unstimulated) migration 
of 8 cells from each group for 8h. Individual cell migration paths from a relative starting 
point (0,0) are shown and net distance traveled was quantified using ImageJ. B) Confluent 
cultures of 10T1/2 cells expressing either mCherry-EV (Control) or mCherry-DNmDia were 
subjected to scratch wound with a P1000 pipette tip and then placed on an inverted 
microscope equipped with a heated, humidified, and O2/CO2 perfused stage. Pictures taken 
every 5 minutes for 24 hr were assembled into movies using Quicktime. Nine cells from 
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each group, starting at the front of the scratch wound, were tracked. The averages of their 
displacement towards the wound was averaged at every time point and plotted for 24 hr. 
Nine cells near the wound edge from each group were tracked for 24 hr. Graphs are oriented 
such that migration toward the scratch wound is indicated by a positive value on the x-axis. 
C) Average displacement of cells from “B” were plotted over time +/− SEM. Repeated 
measurement one-way ANOVA analysis followed by Bonferroni’s post-hoc test for 
individual significance demonstrated that DNmDia expression significantly inhibited 
migration toward the scratch wound (p <0.05). D) 10T1/2 cells expressing either mCherry or 
mCherry-DNmDia were subjected to scratch wound for 8 hrs, fixed, and lamellipodia 
orientation toward or away from the wound was scored in at least 100 cells from three 
separate experiments. E) 10T1/2 cells expressing either mCherry or mCherry-DNmDia were 
subjected to scratch wound for 8 hrs, fixed, and probed for α-Tubulin and stained with DAPI 
to mark MTOC orientation. At least 100 cells were counted in three separate experiments. F) 
Primary rat aortic SMCs expressing either mCherry or mCherry-DNmDia were subjected to 
scratch wound for 8 hrs, fixed, and immunostained for Golgi marker (GM)-130 and DAPI to 
mark orientation. At least 100 cells from three separate experiment were counted. *p <0.05.
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Figure 6. Induction of DNmDia in adult mice inhibited SMC differentiation marker gene 
expression
Control and DNmDia+/SMMHCCre+ mice were injected with tamoxifen IP for 5 
consecutive days. The indicated tissues were harvested after 3 weeks, and frozen sections 
were immunostained for SM MHC. A) Representative images and quantification of SM 
MHC staining. B) Represenative Western blots for DNmDia and SM MHC expression in 
aorta, bladder, and stomach from WT and DNmDia+/SMMHCCre+ mice, three weeks after 
tamoxifen treatment. C) SM MHC expression relative to α-tubulin was quantified using 
image J and then normalized to expression in WT animals set to 1. n=at least 9 animals per 
genotype. *p < 0.05.
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